Terms: = Brain cancer AND NCOA4, RP11-481A12_4, 8031, ENSG00000138293, PTC3, ELE1, Q13772, RFG, DKFZp762E1112, ARA70 AND Clinical Outcome
439 results:
1. Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma.
Vella V; Ditsiou A; Chalari A; Eravci M; Wooller SK; Gagliano T; Bani C; Kerschbamer E; Karakostas C; Xu B; Zhang Y; Pearl FMG; Lopez G; Peng L; Stebbing J; Klinakis A; Giamas G
Adv Sci (Weinh); 2024 Apr; 11(15):e2306027. PubMed ID: 38353396
[TBL] [Abstract] [Full Text] [Related]
2. Survival and neurological outcomes following management of intramedullary spinal metastasis patients: a case series with comprehensive review of the literature.
Kritikos M; Vivanco-Suarez J; Teferi N; Lee S; Kato K; Eschbacher KL; Bathla G; Buatti JM; Hitchon PW
Neurosurg Rev; 2024 Feb; 47(1):75. PubMed ID: 38319484
[TBL] [Abstract] [Full Text] [Related]
3. GammaTile
Yekula A; Gessler DJ; Ferreira C; Shah R; Reynolds M; Dusenbery K; Chen CC
J Neurooncol; 2024 Feb; 166(3):441-450. PubMed ID: 38281303
[TBL] [Abstract] [Full Text] [Related]
4. National multicentered retrospective review of clinical and intraoperative factors associated with the development of cerebellar mutism after pediatric posterior fossa tumor resection.
Kameda-Smith MM; Ragulojan M; Elliott C; Bliss L; Moore H; Sader N; Alsuwaihel M; Tso MK; Dakson A; Ajani O; Yarascavitch B; Fleming A; Mehta V; Aminnejad M; Farrokhyar F; Singh SK;
Childs Nerv Syst; 2024 May; 40(5):1339-1347. PubMed ID: 38279985
[TBL] [Abstract] [Full Text] [Related]
5. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
6. Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact.
Drexler R; Brembach F; Sauvigny J; Ricklefs FL; Eckhardt A; Bode H; Gempt J; Lamszus K; Westphal M; Schüller U; Mohme M
Acta Neuropathol Commun; 2024 Jan; 12(1):9. PubMed ID: 38229158
[TBL] [Abstract] [Full Text] [Related]
7. PATIENT-RELATED FACTORS AND clinical MANAGEMENT outcomeS OF RETINOBLASTOMA IN CALABAR, NIGERIA.
Nkanga ED; Nlemadim AC; Arazi M; Nkanga DG; Duke RE; Fabian ID; Nkanga ED; Odey FA; Meremikwu MM
West Afr J Med; 2023 Dec; 40(12 Suppl 1):S36-S37. PubMed ID: 38070170
[TBL] [Abstract] [Full Text] [Related]
8. Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours.
Simon J; Perez-Rivas LG; Zhao Y; Chasseloup F; Lasolle H; Cortet C; Descotes F; Villa C; Baussart B; Burman P; Maiter D; von Selzam V; Rotermund R; Flitsch J; Thorsteinsdottir J; Jouanneau E; Buchfelder M; Chanson P; Raverot G; Theodoropoulou M
Eur J Endocrinol; 2023 Sep; 189(3):372-378. PubMed ID: 37721395
[TBL] [Abstract] [Full Text] [Related]
9. Molecular Features of Resected Melanoma brain Metastases, clinical outcomes, and Responses to Immunotherapy.
Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
[TBL] [Abstract] [Full Text] [Related]
10. clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.
Kolodziejczak AS; Guerrini-Rousseau L; Planchon JM; Ecker J; Selt F; Mynarek M; Obrecht D; Sill M; Autry RJ; Stutheit-Zhao E; Hirsch S; Amouyal E; Dufour C; Ayrault O; Torrejon J; Waszak SM; Ramaswamy V; Pentikainen V; Demir HA; Clifford SC; Schwalbe EC; Massimi L; Snuderl M; Galbraith K; Karajannis MA; Hill K; Li BK; Walsh M; White CL; Redmond S; Loizos L; Jakob M; Kordes UR; Schmid I; Hauer J; Blattmann C; Filippidou M; Piccolo G; Scheurlen W; Farrag A; Grund K; Sutter C; Pietsch T; Frank S; Schewe DM; Malkin D; Ben-Arush M; Sehested A; Wong TT; Wu KS; Liu YL; Carceller F; Mueller S; Stoller S; Taylor MD; Tabori U; Bouffet E; Kool M; Sahm F; von Deimling A; Korshunov A; von Hoff K; Kratz CP; Sturm D; Jones DTW; Rutkowski S; van Tilburg CM; Witt O; Bougeard G; Pajtler KW; Pfister SM; Bourdeaut F; Milde T
Neuro Oncol; 2023 Dec; 25(12):2273-2286. PubMed ID: 37379234
[TBL] [Abstract] [Full Text] [Related]
11. Venous thromboembolism-related genetic determinant F11 rs4253417 is a potential prognostic factor in ischaemic stroke.
Tavares V; Assis J; Pinto R; Freitas-Silva M; Medeiros R
Mol Cell Probes; 2023 Aug; 70():101917. PubMed ID: 37364690
[TBL] [Abstract] [Full Text] [Related]
12. Two- and three-dimensional endoscopic endonasal surgery of large and giant pituitary adenomas-outcome analysis of a series of 62 patients from a single pituitary center.
Loeschner D; Enciu A; Kellner G; Meyer A; Wallaschofski H; McLean ACL; Gerlach R
Neurosurg Rev; 2023 Jun; 46(1):150. PubMed ID: 37358696
[TBL] [Abstract] [Full Text] [Related]
13. clinical and imaging findings for the evaluation of large Rathke's cleft cysts and cystic craniopharyngiomas.
Yang CH; Wu CH; Lin TM; Chen ST; Tai WA; Yu KW; Luo CB; Lirng JF; Chang FC
Pituitary; 2023 Aug; 26(4):393-401. PubMed ID: 37227614
[TBL] [Abstract] [Full Text] [Related]
14. IRX1 is a novel gene, overexpressed in high-grade IDH-mutant astrocytomas.
Sugur HS; Rao S; Sravya P; Athul Menon K; Arivazhagan A; Mehta B; Santosh V
Pathol Res Pract; 2023 May; 245():154464. PubMed ID: 37116364
[TBL] [Abstract] [Full Text] [Related]
15. A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes.
Mongiorgi S; De Stefano A; Ratti S; Indio V; Astolfi A; Casalin I; Pellagatti A; Paolini S; Parisi S; Cavo M; Pession A; McCubrey JA; Suh PG; Manzoli L; Boultwood J; Finelli C; Cocco L; Follo MY
Clin Epigenetics; 2023 Feb; 15(1):27. PubMed ID: 36803590
[TBL] [Abstract] [Full Text] [Related]
16. Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery-a retrospective, single-center study.
Sumislawski P; Huckhagel T; Krajewski KL; Aberle J; Saeger W; Flitsch J; Rotermund R
Sci Rep; 2023 Feb; 13(1):2468. PubMed ID: 36774403
[TBL] [Abstract] [Full Text] [Related]
17. Neurosurgical management of proton beam therapy-induced moyamoya syndrome.
Zhang CH; Muirhead W; Silva AHD; Toolis C; Robertson F; Rennie A; Bhate S; Thompson DNP; Ganesan V; James G
J Neurosurg Pediatr; 2023 Apr; 31(4):369-379. PubMed ID: 36738468
[TBL] [Abstract] [Full Text] [Related]
18. The diagnostic and prognostic potential of the EGFR/MUC4/MMP9 axis in glioma patients.
Quesnel A; Coles N; Polvikoski TM; Karagiannis GS; Angione C; Islam M; Khundakar AA; Filippou PS
Sci Rep; 2022 Nov; 12(1):19868. PubMed ID: 36400876
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathological Characterization of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
Woo HY; Chae SW; DO SI; Na K
Anticancer Res; 2022 Nov; 42(11):5601-5608. PubMed ID: 36288864
[TBL] [Abstract] [Full Text] [Related]
20. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
[TBL] [Abstract] [Full Text] [Related]
[Next]
